<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00872326</url>
  </required_header>
  <id_info>
    <org_study_id>C/ICPD/2007</org_study_id>
    <secondary_id>FPS C/ICPD/2007</secondary_id>
    <nct_id>NCT00872326</nct_id>
  </id_info>
  <brief_title>Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia</brief_title>
  <official_title>Phase I/II Study of Regenerative Cell Therapy in Treating Diabetic Patients With Critical Limb Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Carlos III Health Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the efficacy and safety of autologous transplantation of
      bone-marrow cells for therapeutic angiogenesis and vasculogenesis in diabetic patients with
      non-revascularizable critical limb ischemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase I/II, prospective, single-center study, with consecutive inclusion of 20 diabetic
      patients with critical limb ischemia due to bellow-the-knee extensive arterial disease.

      After the inclusion, patients are submitted to a bone-marrow aspiration (30 ml) under
      sedation. Autologous bone-marrow mononuclear cells (minimum 80 millions mononuclear cells)
      are infused intraarterially at popliteal artery by blocking antegrade perfusion during 3
      minutes.

      Clinical and angiographic follow-up will be performed at 3 months after the infusion to
      assess the efficacy of autologous mononuclear cells transplantation in terms of:

        -  Changes in below-the-knee angiography from baseline to 3 months follow-up.

        -  Changes in Ankle-Brachial pressure Index, transcutaneous oxygen pressure, and size of
           main ischemic ulcer will be also assessed at target limb.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic evaluation of angiogenesis and vasculogenesis at target limb</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ankle-Brachial pressure index</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <condition>Diabetic Foot</condition>
  <arm_group>
    <arm_group_label>Autologous Bone Marrow Mononuclear Cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consecutive inclusion among diabetic patients with critical limb ischemia. Intraarterial infusion of autologous bone marrow mononuclear cells</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous Bone Marrow Mononuclear Cells</intervention_name>
    <description>Infusion &gt; 80 millions mononuclear cells. Intraarterial administration at popliteal artery level. Infusion during 3 minutes with antegrade blockage of arterial flow.</description>
    <arm_group_label>Autologous Bone Marrow Mononuclear Cells</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetic patients under treatment (type I or II)

          -  Critical limb ischemia (rest pain and/or non-healing ischemic ulcers lasting more than
             4 weeks, and/or Ankle-Brachial Index &lt; 0,8)

          -  Not suitable to be revascularized (surgical and interventional consensus)

        Exclusion Criteria:

          -  Neoplastic disease and/or hematologic disease during the last 2 years

          -  Diabetic retinopathy

          -  Ischemic ulcer greater than 10 cm2

          -  Major amputation at target limb

          -  Life expectancy &gt; 2 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio de la Cuesta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Critical Limb Ischemia Unit. Hospital Universitario Virgen Macarena and Hospital San Lazaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Constantino, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chief of Hematology. Hospital Universitario Virgen Macarena</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rafael J Ruiz-Salmeron, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chief of Endovascular Unit. Hospital Universitario Virgen Macarena</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Virgen Macarena</name>
      <address>
        <city>Seville</city>
        <zip>41007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2009</study_first_submitted>
  <study_first_submitted_qc>March 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2009</study_first_posted>
  <last_update_submitted>November 13, 2014</last_update_submitted>
  <last_update_submitted_qc>November 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes Complications</keyword>
  <keyword>Lower limb ischemia</keyword>
  <keyword>Adult stem cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

